TheraCell Inc., a leading allograft solution company, has completed the first surgical case using its TheraFuze DBF Fiber Bullets. This unique DBF fiber form is designed for minimal access delivery into expandable cages, revisions and other surgical applications.
The case was performed by Dr. Neel Anand, MD, Mch. Orth. (Liverpool), FAAOS, Professor of Orthopaedic Surgery and Director, Spine Trauma, Cedars Sinai Medical Center, and Chairman of Orthopaedics and Spine, Minimally invasive Spine Surgery, DOCS Surgical Hospital, Beverly Hills. The case was an L3-L4 PSF with interbody TLIF at L3-L4. Dr. Anand used several TheraFuze DBF Fiber Bullets to fill the interbody space, as well as TheraFuze DBF FiberForm combined with auto graft in the cage.
Describing the surgical procedure Dr. Anand said: “After discectomy and endplate preparation to accept the TLIF cage, I placed several Fiber Bullets in the lyophilized state anterior to the implant to fill the interbody space with graft material. Subsequent to the cage insertion, several additional Fiber Bullets were placed posterior to the cage to ensure complete endplate to endplate apposition of the TheraFuze DBF allograft in the interbody. I placed 1cc of DBF FiberForm combined with autograft in the lumen of the TLIF cage.” Additionally, he stated, “Delivery of the bullets through a cannula is a very convenient option. The entire procedure was quite simple and fit into my usual surgical process with ease.”
The TheraFuze DBF Fiber Bullets are made from cortical demineralized bone fibers, processed using TheraCell’s proprietary and patented technologies. These processes have been developed to produce uniform fiber geometry, size and texture, and to preserve the natural collagen structure of the allograft, providing surgeons with a 100% natural allograft that is osteoconductive with osteoinductive potential and enhanced handling properties ideal for spinal fusion and other orthopedic applications.
